Scientists
group fluoroquinolones into two groups, with drugs belonging to each of the groups sharing certain pharmacological and antimicrobial activity.
Not exact matches
The FDA's actions came shortly after a lawsuit was filed by consumer advocacy
group Public Citizen, which for years had attempted to convince the FDA to issue stronger warnings about the side effects of Levaquin and other
fluoroquinolones.
Thanks to pressure on the part of these
groups and states such as Illinois, in 2008 the FDA finally forced the manufacturers of Cipro, Levaquin and other
fluoroquinolones to create Medical Guides and add black box warnings to the packaging of these products.
For years consumer advocacy
groups and others have fought, with little success, to increase public awareness of these product defect legal liabilities and require the manufacturers of
fluoroquinolones to participate in these efforts.
Groups at highest risk of developing side effects from taking
fluoroquinolones include those over 60 years of age and people who have had heart, lung or kidney transplants.